• CAS
  • |
  • C&EN
  • |
  • Journals
  • |
  • ACS

search site
Advanced Search »
  • Home
  • |
  • About CAS
    • CAS Media Library
    • CAS Quotes
    • Colors of Chemistry
    • 100th Anniversary Celebration
    • Careers at CAS
    • FAQs
    • Directions to CAS
    • Contact Us
  • |
  • Our Expertise
    • CAS Databases
    • Value Added Tools
    • Technical Service and Support
  • |
  • Solutions
    • Researchers
    • IP Professionals
    • Information Professionals
    • Academics
  • |
  • Products & Services
    • SciFinder
    • STN Family of Products
    • Science IP
    • CAS Client Services
    • CAS Document Detective Service
    • CD Products
    • Print Products
  • |
  • Support & Training
    • SciFinder
    • SciFinder Scholar
    • STN
    • STN Express
    • STN AnaVist
    • STN Viewer
    • STN on the Web
    • STN Easy
    • CAS Customer Care
  • |
  • News & Events
    • What's New
    • Press Room
    • News Releases
    • In the News
    • Trade Shows
  • CAS Science Spotlight Home
  • Most Cited Journal Articles 2003-Medical Sciences
  • About
  • What's New
Home   •   Spotlight  •  medsci03  •  Most Cited Journal Articles 2003-Medical Sciences (5)
Most Cited Journal Articles 2003-Medical Sciences
spotlightlogo.gif

Following is a CAS database record representing a highly cited journal article.



CAS subject entries for this document include: Lymphoma; Diagnosis; Neoplasm; and 3 additional concepts.

CAPLUS COPYRIGHT 2004 ACS on STN

TITLE: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AUTHOR(S): Alizadeh, Ash A.; Eisen, Michael B.; Davis, R. Eric; Ma, Chi; Lossos, Izidore S.; Rosenwald, Andreas; Boldrick, Jennifer C.; Sabet, Hajeer; Tran, Truc; Yu, Xin; Powell, John I.; Yang, Liming; Marti, Gerald E.; Moore, Troy; Hudson, James, Jr.; Luo, Lisheng; Lewis, David B.; Tibshirani, T, Robert; Sherlock, Gavin; Chan, Wing C.; Greiner, Timothy C.; Weisenburger, Dennis D.; Armitage, James O.; Wamke, Roger; Levy, Ronald; Wilson, Wyndham; Grever, Michael R.; Byrd, John C.; Botstein, David; Brown, Patrick O.; Staudt, Louis M.
CORPORATE SOURCE: Departments of Biochemistry, Genetics, Pathology, Medicine, Pediatrics and Health Research & Policy and Statistics, and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA
SOURCE: Nature (London) (2000), 403(6769), 503-511 CODEN: NATUAS; ISSN: 0028-0836
PUBLISHER: Nature Publishing Group
LANGUAGE: English
ABSTRACT:
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clin. heterogeneous: 40% of patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease. We proposed that this variability in natural history reflects unrecognized mol. heterogeneity in the tumors. Using DNA microarrays, we have conducted a systematic characterization of gene expression in B-cell malignancies. Here we show that there is diversity in gene expression among the tumors of DLBCL patients, apparently reflecting the variation in tumor proliferation rate, host response and differentiation state of the tumor. We identified two molecularly distinct forms of DLBCL which had gene expression patterns indicative of different stages of B-cell differentiation. One type expressed genes characteristic of germinal center B cells ('germinal center B-like DLBCL'); the second type expressed genes normally induced during in vitro activation of peripheral blood B cells ('activated B-like DLBCL'). Patients with germinal center B-like DLBCL had a significantly better overall survival than those with activated B-like DLBCL. The mol. classification of tumors on the basis of gene expression can thus identify previously undetected and clin. significant subtypes of cancer.

View the full-text pdf document from the Nature Publishing Group.

Updated 4/26/2007 10:42:53 AM
Home  |  About CAS  |  Our Expertise  |  Solutions  |  Products & Services  |  Support  |  News & Events
Copyright © 2008 American Chemical Society